Feedback / Questions
OPN-2853 - Opna Bio
https://www.businesswire.com/news/home/20251208736143/en/Opna-Bio-Showcases-Multi-Functional-Degraders-with-Potent-Anti-Myeloma-Activity-and-Encouraging-Spleen-Reductions-in-Patients-with-Myelofibrosis-Treated-with-OPN-2853-and-Ruxolitinib
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next